SPP1 and cancer: Thus, in this study, we tried to accurately evaluate the SPP1 expression status on cancer cells and TAMs separately in patients with NSCLC by double-IHC, and demonstrated that only SPP1 expression on TAMs predicted a poor prognosis in lung adenocarcinoma patients.